These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1071 related articles for article (PubMed ID: 15262836)

  • 1. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials.
    Wan S; Quinlan DJ; Agnelli G; Eikelboom JW
    Circulation; 2004 Aug; 110(6):744-9. PubMed ID: 15262836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis versus anticoagulation for the initial treatment of moderate pulmonary embolism: a meta-analysis of randomized controlled trials.
    Chen H; Ren C; Chen H
    Respir Care; 2014 Dec; 59(12):1880-7. PubMed ID: 25269681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short term effect of recombinant tissue plasminogen activator in patients with hemodynamically stable acute pulmonary embolism: results of a meta-analysis involving 464 patients.
    Tardy B; Venet C; Zeni F; Coudrot M; Guyomarc'h S; Mismetti P
    Thromb Res; 2009 Dec; 124(6):672-7. PubMed ID: 19493561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.
    Eikelboom JW; Quinlan DJ; Mehta SR; Turpie AG; Menown IB; Yusuf S
    Circulation; 2005 Dec; 112(25):3855-67. PubMed ID: 16344381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based emergency medicine/critically appraised topic. Thrombolytic therapy for submassive pulmonary embolism?
    Worster A; Smith C; Silver S; Brown MD
    Ann Emerg Med; 2007 Jul; 50(1):78-84. PubMed ID: 17449142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of thrombolytic therapy in pulmonary embolism: meta-analysis of randomized controlled trials].
    Serra-Prat M; Jovell AJ; Aymerich M
    Med Clin (Barc); 1999 May; 112(18):685-9. PubMed ID: 10374198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolism.
    Perlroth DJ; Sanders GD; Gould MK
    Arch Intern Med; 2007 Jan; 167(1):74-80. PubMed ID: 17210881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of thrombolysis and anticoagulation in pulmonary thromboembolism: a meta-analysis].
    Qin ZQ; Wang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Dec; 26(12):772-5. PubMed ID: 14720434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of unfractionated heparin and low molecular weight heparin in pulmonary thromboembolism: meta-analysis].
    Zhai ZG; Wang C; Liu YM; Qin ZQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):221-6. PubMed ID: 15266820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolytic therapy for acute pulmonary embolism.
    Sharma G; Kothari SS; Bahl VK
    Indian Heart J; 2002; 54(6):667-71. PubMed ID: 12674177
    [No Abstract]   [Full Text] [Related]  

  • 14. Possible gender-related differences in the risk-to-benefit ratio of thrombolysis for acute submassive pulmonary embolism.
    Geibel A; Olschewski M; Zehender M; Wilsch M; Odening K; Heinrich F; Kasper W; Konstantinides S
    Am J Cardiol; 2007 Jan; 99(1):103-7. PubMed ID: 17196471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute circulatory failure caused by primary pulmonary hypertension or pulmonary embolism].
    Meyer G; Sanchez O
    Rev Mal Respir; 2000 Feb; 17(1):51-65. PubMed ID: 10756556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant tissue plasminogen activator for hemodynamically stable patients experiencing an acute pulmonary embolism: a meta-analysis.
    Liu Y; Lu Y; Song J; Li D; Liu H; Yang J; Zhao H
    Thromb Res; 2014 Jul; 134(1):50-6. PubMed ID: 24824292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials.
    De Luca G; Marino P
    Am Heart J; 2007 Dec; 154(6):1085.e1-6. PubMed ID: 18035079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy for pulmonary embolism.
    Hao Q; Dong BR; Yue J; Wu T; Liu GJ
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD004437. PubMed ID: 30560579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and cost effectiveness of thrombolysis in patients with acute pulmonary embolism.
    Zamanian RT; Gould MK
    Curr Opin Pulm Med; 2008 Sep; 14(5):422-6. PubMed ID: 18664972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis.
    Chatterjee S; Chakraborty A; Weinberg I; Kadakia M; Wilensky RL; Sardar P; Kumbhani DJ; Mukherjee D; Jaff MR; Giri J
    JAMA; 2014 Jun; 311(23):2414-21. PubMed ID: 24938564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.